Biodesix (BDSX) Retained Earnings (2019 - 2026)

Biodesix (BDSX) has 8 years of Retained Earnings data on file, last reported at -$505.6 million in Q1 2026.

• Quarterly Retained Earnings fell 6.75% year-over-year to -$505.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$505.6 million (down 6.75% YoY) and the FY2025 annual result came in at $495.3 million, up 207.09% from the prior year.
• Retained Earnings fell to -$505.6 million in Q1 2026, from $495.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $495.3 million in Q4 2025 to a low of -$505.6 million in Q1 2026.
• A 5-year average of -$26.1 million and a median of -$347.1 million in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2023 — Retained Earnings sank 217.14% — and 2024, when it soared 220.18%.
• Tracing BDSX's Retained Earnings over 5 years: stood at -$367.4 million in 2022, then fell by 14.19% to -$419.6 million in 2023, then declined by 10.23% to -$462.5 million in 2024, then surged by 207.09% to $495.3 million in 2025, then tumbled by 202.07% to -$505.6 million in 2026.
• The last three Retained Earnings figures came in at -$505.6 million (Q1 2026), $495.3 million (Q4 2025), and $492.1 million (Q3 2025), per Business Quant data.